An approach that would deserve further investigation is a local or systemic administration of the growth factor PDGFRB, which is critical for the maintenance of pericyte vessel coverage and normal BBB function [68] and has already been tested in experimental models of status epilepticus or Parkinson’s disease with positive results [69]. This evidence concerns the gene PDGFRB and Parkinson disease.